NCT04045431View on ClinicalTrials.gov

Treatment of Knee Osteoarthritis With PAAG-OA

NAActive, not recruitingINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

October 1, 2020

Study Completion Date

November 30, 2026

Conditions
Osteoarthritis, Knee
Interventions
DEVICE

PAAG-OA

Intra-articular injection of 6ml PAAG-OA in the target knee (incl. five (5) years follow-up) period.

DEVICE

Synvisc-One

Intra-articular injection of 6ml Synvisc-One in the target knee

Trial Locations (3)

Unknown

The Parker Institute, Frederiksberg

A2 Reumatologi og idrætsmedicin, Hillerød

Reumatolog i Odense, Odense

Sponsors

Lead Sponsor

Contura
All Listed Sponsors
lead

Contura

INDUSTRY

NCT04045431 - Treatment of Knee Osteoarthritis With PAAG-OA | Biotech Hunter | Biotech Hunter